Donaldson Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $361K | Hold |
1,234
| – | – | 0.01% | 198 |
|
|
2025
Q4 | $432K | Sell |
1,234
-40
| -3% | -$13.5K | 0.01% | 185 |
|
|
2025
Q3 | $412K | Sell |
1,274
-169
| -12% | -$52.6K | 0.01% | 181 |
|
|
2025
Q2 | $561K | Buy |
1,443
+1
| +0.1% | +$402 | 0.02% | 166 |
|
|
2025
Q1 | $627K | Sell |
1,442
-582
| -29% | -$234K | 0.02% | 160 |
|
|
2024
Q4 | $747K | Sell |
2,024
-236
| -10% | -$98.8K | 0.03% | 147 |
|
|
2024
Q3 | $1.17M | Sell |
2,260
-4,210
| -65% | -$2.25M | 0.05% | 125 |
|
|
2024
Q2 | $3.51M | Buy |
6,470
+808
| +14% | +$427K | 0.15% | 72 |
|
|
2024
Q1 | $2.94M | Buy |
5,662
+3,638
| +180% | +$1.81M | 0.12% | 78 |
|
|
2023
Q4 | $955K | Sell |
2,024
-421
| -17% | -$195K | 0.04% | 126 |
|
|
2023
Q3 | $1.06M | Hold |
2,445
| – | – | 0.05% | 122 |
|
|
2023
Q2 | $1.09M | Hold |
2,445
| – | – | 0.05% | 117 |
|
|
2023
Q1 | $1.12M | Hold |
2,445
| – | – | 0.05% | 107 |
|
|
2022
Q4 | $1.25M | Hold |
2,445
| – | – | 0.06% | 101 |
|
|
2022
Q3 | $1.11M | Sell |
2,445
-5
| -0.2% | -$2.39K | 0.06% | 100 |
|
|
2022
Q2 | $1.18M | Sell |
2,450
-4
| -0.2% | -$1.98K | 0.06% | 103 |
|
|
2022
Q1 | $1.21M | Buy |
2,454
+2
| +0.1% | +$914 | 0.05% | 113 |
|
|
2021
Q4 | $1.14M | Buy |
2,452
+17
| +0.7% | +$7.15K | 0.05% | 117 |
|
|
2021
Q3 | $908K | Buy |
2,435
+1
| +0% | +$380 | 0.05% | 119 |
|
|
2021
Q2 | $929K | Hold |
2,434
| – | – | 0.05% | 113 |
|
|
2021
Q1 | $874K | Hold |
2,434
| – | – | 0.05% | 113 |
|
|
2020
Q4 | $781K | Sell |
2,434
-9
| -0.4% | -$2.76K | 0.05% | 114 |
|
|
2020
Q3 | $656K | Sell |
2,443
-1
| -0% | -$269 | 0.04% | 113 |
|
|
2020
Q2 | $643K | Sell |
2,444
-8
| -0.3% | -$2.13K | 0.05% | 113 |
|
|
2020
Q1 | $557K | Hold |
2,452
| – | – | 0.05% | 106 |
|
|
2019
Q4 | $741K | Sell |
2,452
-27
| -1% | -$7.43K | 0.05% | 108 |
|
|
2019
Q3 | $595K | Buy |
2,479
+537
| +28% | +$147K | 0.04% | 111 |
|
|
2019
Q2 | $548K | Buy |
1,942
+97
| +5% | +$26.5K | 0.05% | 104 |
|
|
2019
Q1 | $530K | Buy |
1,845
+646
| +54% | +$187K | 0.05% | 103 |
|
|
2018
Q4 | $315K | Sell |
1,199
-7
| -0.6% | -$1.93K | 0.03% | 122 |
|
|
2018
Q3 | $331K | Buy |
1,206
+7
| +0.6% | +$1.82K | 0.03% | 135 |
|
|
2018
Q2 | $285K | Hold |
1,199
| – | – | 0.03% | 145 |
|
|
2018
Q1 | $263K | Hold |
1,199
| – | – | 0.03% | 141 |
|
|
2017
Q4 | $270K | Hold |
1,199
| – | – | 0.03% | 143 |
|
|
2017
Q3 | $228K | Sell |
1,199
-4
| -0.3% | -$761 | 0.02% | 145 |
|
|
2017
Q2 | $226K | Buy |
+1,203
| New | +$216K | 0.03% | 139 |
|
Other funds holding ELV
VCM
VPM
Donaldson Capital Management's ELV Position: Q1 2026 in Review
Donaldson Capital Management held its Elevance Health (ELV) position steady in Q1 2026 at 1,234 shares worth $361K. The position accounts for 0.01% of the portfolio, ranked #198.
Donaldson Capital Management first reported a position in ELV in Q2 2017 and has held it in 36 quarters since. The position peaked at $3.51M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Donaldson Capital Management held 1,234 shares of Elevance Health worth $361K as of Q1 2026.
- Donaldson Capital Management left its Elevance Health share count unchanged in Q1 2026.
- Elevance Health made up 0.01% of Donaldson Capital Management's portfolio in Q1 2026, its #198 holding.
- Donaldson Capital Management first reported a position in Elevance Health in Q2 2017 and has held it in 36 quarters since.
- Donaldson Capital Management's Elevance Health position peaked at $3.51M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Donaldson Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.